Home › Employers › Boston IVF, LLC
Boston IVF, LLC: H-1B salaries and sponsorship
Boston IVF, LLC filed 4 labor condition applications for H-1B and related visas in fiscal years 2023–2026; certified: 3. Median offered salary: $105,331.
Does Boston IVF, LLC sponsor H-1B visas?
Boston IVF, LLC filed 4 labor condition applications in fiscal years 2023–2026, the latest submitted on Mar 28, 2025. An LCA is the first step of an H-1B petition, so the employer has sponsored or prepared to sponsor H-1B workers; it does not guarantee sponsorship for any particular job. Check the employer's own job listings.
Salaries by job title
| Job title | LCAs | Median salary |
|---|---|---|
| Reproductive Endocrinologist | 2 | $349,981 |
| Senior Embryologist | 1 | $105,331 |
| Embryologist | 1 | $69,971 |
Applications by fiscal year
| Fiscal year | LCAs | Median salary |
|---|---|---|
| FY2024 | 3 | $227,656 |
| FY2025 | 1 | $69,971 |
Prevailing wage levels
The Department of Labor sets four prevailing wage levels for each occupation and area, from Level I (entry) to Level IV (fully competent). The employer picks the level that matches the job's requirements.
Where the jobs are
Occupations
Latest applications
| Job title | Base salary | Location | Submitted | Start date | Status |
|---|---|---|---|---|---|
| Embryologist | $69,971–$69,992 E-3 · Level I | Waltham, MA | Mar 28, 2025 | May 27, 2025 | Certified |
| Senior Embryologist | $105,331–$113,048 E-3 · Level III | Waltham, MA | Aug 27, 2024 | Jan 15, 2025 | Certified |
| Reproductive Endocrinologist | $349,981–$399,984 E-3 · Level III | Waltham, MA | Jul 8, 2024 | Sep 1, 2024 | Certified |
| Reproductive Endocrinologist | $349,981–$399,984 E-3 | Waltham MA, MA | Jul 1, 2024 | Sep 1, 2024 | Denied |
Salaries are the lower end of the wage offered on each application, converted to a yearly amount; statistics use certified full-time applications only. An LCA is not a visa approval and one LCA can cover several positions. Source: U.S. Department of Labor, OFLC LCA Disclosure Data, fiscal years 2023–2026 (latest decision Jun 30, 2026).